Biological evaluation of medical devices — Part 19: Physico-chemical, morphological and topographical characterization of materials
Introduction: ISO 14971 highlights the importance of taking into account the nature of the materials within a biological risk analysis. ISO 10993-1 is to serve as a framework in which to plan a biological evaluation which, as scientific knowledge advances human understanding of the basic mechanisms of tissue responses, minimizes the number and exposure of test animals by giving preference to chemical constituent testing and in vitro models. In situations where these methods yield equally relevant information to that obtained from in vivo models, ISO 10993-1 states that, when selecting the materials to be used for device manufacture, fitness for purpose with regards to characteristics and properties of the material, which include chemical, toxicological, physical, electrical, morphological and mechanical properties, will be the first consideration. The identification and evaluation of the physico-chemical, morphological and topographical properties of materials used in a finished medical device are important in determining the biological evaluation of that device and its materials. Such information can be used in: — assessing the overall biological evaluation of a medical device according to ISO 10993; — screening of potential new materials and/or processes for suitability in a medical device for a proposed clinical application. The compositional characteristics of the materials of manufacture are mainly under the control of the suppliers of these materials. However, other characteristics a
Scope: This document provides a compilation of parameters and test methods that can be useful for the identification and evaluation of the physical, i.e. physico‑chemical, morphological and topographical (PMT) properties of materials in finished medical devices. Such an assessment is limited to those properties that are relevant to biological evaluation and the medical device’s intended use (clinical application and duration of use) even if such properties overlap with clinical effectiveness. This document does neither address the identification or quantification of degradation products nor the evaluation of the physico-chemical properties of the degraded materials, which are covered in ISO 10993-9, ISO 10993-13, ISO 10993-14 and ISO 10993-15. Chemical characterization of materials is covered by ISO 10993-18. The ISO 10993 series is not applicable when the material or device is not in contact with the body directly or indirectly.